The NFL and NFL Players Association confirmed a joint investigation into how the Eagles managed Jalen Hurts' blood clot diagnosis before clearing him to keep playing.
Eagles medical review and Hurts' condition
- The NFL and NFLPA will jointly review the Eagles' medical decisions. The union pushed for the probe after the league initially said no investigation was needed.
- Hurts played despite an early blood clot finding on Oct. 10. A follow-up exam later revealed the clot had moved, leading to a deep vein thrombosis and bilateral pulmonary emboli diagnosis on Oct. 19.
- Hurts is now on injured reserve for the season. He is being treated with blood thinners, which doctors warn raises injury risk if he returns to contact play.
The case puts fresh scrutiny on team medical protocols and player safety oversight across professional football.
Summarized by MalakyeAI
